why choose us

Clinical Trials Search

Showing 10,060 of 132,656 result(s)
Adapting the Shed-MEDS Deprescribing Intervention to Dementia Care in Assisted Living

Status: NOT_YET_RECRUITING

Condition: Polypharmacy

Interventions: See single arm description

Date: 2023-07-11

Heme and Non-heme Iron Intakes, Gut Microbiota, and Influence on Host Iron Absorption

Status: Completed

Condition: Anemia, Iron Deficiency

Interventions:

Date: 2023-07-11

Frequency and E-field Enhancement of ITBS for Depression (FREED)

Status: Completed

Condition: Major Depressive Disorder

Interventions: Repetitive transcranial magnetic stimulation (rTMS) is a safe and effective treatment for TRD that is increasingly being used in clinical practice acr

Date: 2023-07-11

Digital Equity for Stroke Approach

Status: Completed

Condition: Stroke

Interventions: Intervention group is monitored via remote bp monitoring and telehealth device.

Date: 2023-07-11

Home-based tDCS in Frontotemporal Dementia or Alzheimer's Disease

Status: Completed

Condition: Mild Cognitive Impairment

Interventions: Computerized Cognitive training (BrainHQ)

Date: 2023-07-11

Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines

Status: Completed

Condition: Parkinson Disease

Interventions: Twenty-five participants with PD utilizing the Medtronic Percept PC DBS system will be enrolled for this project and complete a single bout of both FE

Date: 2023-07-11

Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study

Status: Completed

Condition: Pancreatic Neoplasm

Interventions: Undergo EUS-guided chemoablation

Date: 2023-07-11

A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder

Status: Completed

Condition: Tourette Syndrome

Interventions: Selective dopamine D1 and D5 receptor antagonist

Date: 2023-07-11

High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners

Status: Completed

Condition: Neurologic Disorder

Interventions: Exercise sessions will be 60 to 75 minutes in duration and be a combination of resistance, aerobic, and balance exercise, with emphasis on functional

Date: 2023-07-11

Trial of Idasanutlin and Selinexor Therapy for Children With Progressive;Relapsed AT;RT or Extra-CNS Malignant Rhabdoid Tumors

Status: NOT_YET_RECRUITING

Condition: Rhabdoid Tumor

Interventions: Patients will receive idasanutlin dosed once daily on Days 1-5 of a 28-day cycle starting with 80% of the RP2D determined in the ongoing pediatric iMA

Date: 2023-07-11